Form 4 Filing for Apellis Pharmaceuticals, Inc.

Caroline Baumal, Chief Medical Officer of Apellis Pharmaceuticals, Inc., reported a disposition of 900 shares of common stock on April 29, 2026. The transaction code was 'G' with a price of $0.00 per share, indicating a charitable contribution as noted by footnote F1. Following this transaction, Baumal holds 86,525 shares. Footnote F2 indicates that this total includes 898 shares from an ESPP purchase on April 30, 2026. The filing was signed by David Watson as attorney-in-fact for Caroline Baumal on May 1, 2026.